RED LIGHT HOLLAND CORP. Market Cap ($6.62 Million)
Market Cap & Net Worth: RED LIGHT HOLLAND CORP. (4YX)
RED LIGHT HOLLAND CORP. market cap. RED LIGHT HOLLAND CORP. (F:4YX) has a market capitalization of $6.62 Million (€5.66 Million) as of November 1, 2026. Listed on the F stock exchange, this Germany-based company holds position #27932 globally and #2393 in its home market, demonstrating a 23.38% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying RED LIGHT HOLLAND CORP.'s stock price €0.01 by its total outstanding shares 595727901 (595.73 Million). Also see 4YX cash flow metrics for how efficiently the company converts equity into cash flow.
RED LIGHT HOLLAND CORP. Market Cap History (2020–2026)
RED LIGHT HOLLAND CORP. market cap history from 2020 to 2026. Data shows change from $142.08 Million to $6.62 Million (-31.54% CAGR). Check current stock price of RED LIGHT HOLLAND CORP. for real-time trading data and today's change.
RED LIGHT HOLLAND CORP. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how RED LIGHT HOLLAND CORP.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 4YX shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.58x
RED LIGHT HOLLAND CORP.'s market cap is 1.58 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $39.35 Million | $2.33 Million | -$14.37 Million | 16.92x | N/A |
| 2023 | $24.38 Million | $3.95 Million | -$5.40 Million | 6.17x | N/A |
| 2024 | $17.41 Million | $4.75 Million | -$7.63 Million | 3.66x | N/A |
| 2025 | $6.96 Million | $4.94 Million | -$4.04 Million | 1.41x | N/A |
| 2026 | $6.62 Million | $4.20 Million | -$6.10 Million | 1.58x | N/A |
Competitor Companies of 4YX by Market Capitalization
Companies near RED LIGHT HOLLAND CORP. in the global market cap rankings as of November 1, 2026. Also see RED LIGHT HOLLAND CORP. total assets for a full breakdown of the balance sheet.
Key companies related to RED LIGHT HOLLAND CORP. by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of RED LIGHT HOLLAND CORP. (2020–2026)
Market capitalization of RED LIGHT HOLLAND CORP. from 2020 to today. Between 2020 and today, RED LIGHT HOLLAND CORP.'s market cap moved from $142.08 Million to $ 6.62 Million, with a yearly change of -31.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €6.62 Million | -5.00% |
| 2025 | €6.96 Million | -60.00% |
| 2024 | €17.41 Million | -28.57% |
| 2023 | €24.38 Million | -38.05% |
| 2022 | €39.35 Million | -43.50% |
| 2021 | €69.65 Million | -50.98% |
| 2020 | €142.08 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of RED LIGHT HOLLAND CORP. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.62 Million USD |
| MoneyControl | $6.62 Million USD |
| MarketWatch | $6.62 Million USD |
| marketcap.company | $6.62 Million USD |
| Reuters | $6.62 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About RED LIGHT HOLLAND CORP.
Rhelion Life Sciences Corp. engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe. The company is also involved in the selection, distribution, and export of truffles, cannabidiol products, cannabis seeds, headshop products, growshop goods, cannabis bake house muffins, cookies, and cakes. Its products… Read more